Biotech · Private company
Embera NeuroTherapeutics, Inc.
Track this companyFree. Adds Embera NeuroTherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- EMB-001Phase 2 · Cocaine Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- EMB-001Phase 2 · Tobacco Use DisorderClinicalTrials.gov · fetched Nov 12, 2026
- MetyraponeCocaine DependenceClinicalTrials.gov · fetched Nov 12, 2026
- OxazepamCocaine DependenceClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of EMB-001 as a Potential Smoking Cessation TreatmentPHASE1_PHASE2 · TERMINATED · started Jun 10, 2021ClinicalTrials.gov NCT04933916 · fetched Nov 12, 2026
- Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation TreatmentPHASE2_PHASE3 · UNKNOWN · started May 19, 2021ClinicalTrials.gov NCT04868253 · fetched Nov 12, 2026
- A Study to Evaluate EMB 001 in Subjects With Cocaine Use DisorderPHASE2 · COMPLETED · started Jul 29, 2020ClinicalTrials.gov NCT04501874 · fetched Nov 12, 2026
- A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine AddictionNA · COMPLETED · started Dec 1, 2007ClinicalTrials.gov NCT00567814 · fetched Nov 12, 2026